Here, we report for the first time a study on EBP50 expression, and the impact of HR-HPV on EBP50 expression in HNSCC tumours in order to establish its validity as a novel biomarker of HR-HPV infection in HNSCC. This evidence concerns the gene NHERF1 and neoplasm.